课题基金 / 基金详情

项目摘要

项目成果

Xiang-Qun Xie的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The marijuana (or cannabinoid, CB) receptors are classified as members of rhodopsin-like G-protein coupled receptors (GPCRs) family that represents ~45% of current drugs worldwide. In fact, due to the intrinsic properties of membrane proteins, very few high-resolution structures have been reported for any GPCRs due to the lack of high-quality crystals suitable for X-ray crystallography studies, or uniformly isotope-labeled "native" proteins for NMR studies. The most important is due to the fact that very limited protein expression systems have proven satisfactory for producing the full-length GPCRs in a functional state and with sufficient yields for biophysical studies. The objective of this research to further develop and improve our established CB2 membrane protein (MP) structural biology approaches, and then applies these structural and functional parameters to refine the homology-generated 3D CB2 structure model. The long range goal is to develop the CB2 receptor structure model for rational CB2 ligand design via understanding of the structural and functional events associated with CB2 receptor. Specifically, we will target the following aims: Aim1. MD simulations to refine the predicted 3D GPCR CB2 receptor structure models (preliminary work completed with two publications). Aim2: Further molecular dynamics (MD) calculations of the 3D CB2 receptor structure in membrane model (using GROMACS for MD simulation of the CB2 receptor in the lipid/water simulated bilayer membrane system. Such a large biosystem requires high power computing facility that is available @PSC. Aim3: Carry out receptor docking studies to explore the active ligand binding conformations and further evaluate the binding energy using QM approaches, including. GAUSSIAN for ab initio computations The accomplished work is expected to make a valuable contribution to cannabinoid research in particular and GPCR NMR structural biology in general. The potential significance of the work proposed is that it would contribute greatly to our ability to design immunomodulatory drugs that act solely at the cannabinoid CB2 receptor. These drugs could be potential therapeutic agents for autoimmune diseases and immunological disorders such as Multiple Sclerosis, Lupus, and neuroinflammatory pains, etc.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SmartAD for Intelligent Alzheimer’s Disease(AD) Personalized Combination Therapy
SmartAD for Intelligent Alzheimer’s Disease(AD) Personalized Combination Therapy
Cannabinoid CB2 Receptor Structure and Allosteric Modulators
Cannabinoid CB2 Receptor Structure and Allosteric Modulators
国内基金
海外基金
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
  • 批准号:
    32170319
  • 项目类别:
    面上项目
  • 资助金额:
    58.00万元
  • 批准年份:
    2021
  • 负责人:
    董春海
  • 依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
  • 批准号:
    --
  • 项目类别:
    --
  • 资助金额:
    58万元
  • 批准年份:
    2021
  • 负责人:
    董春海
  • 依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
  • 批准号:
    31372080
  • 项目类别:
    面上项目
  • 资助金额:
    80.0万元
  • 批准年份:
    2013
  • 负责人:
    杨迎伍
  • 依托单位: